Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006-Reference-Cited by-同舟云学术

Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006

Published:2021-11 Issue: Volume:157 Page:391-402
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Hamid Omid^ORCID,Robert Caroline,Daud Adil,Carlino Matteo S.,Mitchell Tara C.,Hersey Peter^ORCID,Schachter Jacob,Long Georgina V.^ORCID,Hodi F. Stephen,Wolchok Jedd D.,Arance Ana,Grob Jean Jacques,Joshua Anthony M.^ORCID,Weber Jeffrey S.,Mortier Laurent,Jensen Erin,Diede Scott J.^ORCID,Moreno Blanca Homet,Ribas Antoni

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Melanoma;Schadendorf;Lancet,2018

2. Targeted agents and immunotherapies: optimizing outcomes in melanoma;Luke;Nat Rev Clin Oncol,2017

3. NCCN clinical practice guidelines in oncology. cutaneous melanoma. Version 3.2020;National Comprehensive Cancer Network,2020

4. Melanoma: prognostic factors and factors predictive of response to therapy;Strudel;Curr Med Chem,2020

5. Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Michielin;Ann Oncol,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Melanoma: An Overview of Physiological and Therapeutic Aspects and Biotechnological Use of Serine Protease Inhibitors;Molecules;2024-08-16

2. Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review;Frontiers in Oncology;2024-07-16

3. The path to leptomeningeal metastasis;Nature Reviews Cancer;2024-06-13

4. ANALYSIS OF MAGNETIC RESONANCE PROBE-BASED OXALIPLATIN-RESVERATROL DRUG RELEASE-CONTROLLED NANOPARTICLE THERAPY FOR COLORECTAL CANCER;FARMACIA;2024

5. The Use of Fecal Microbiota Transplant in Overcoming and Modulating Resistance to Anti-PD-1 Therapy in Patients with Skin Cancer;Cancers;2024-01-24